Literature DB >> 17255119

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.

Jean Addington1, Kristin S Cadenhead, Tyrone D Cannon, Barbara Cornblatt, Thomas H McGlashan, Diana O Perkins, Larry J Seidman, Ming Tsuang, Elaine F Walker, Scott W Woods, Robert Heinssen.   

Abstract

This article presents the rationale, design, and preliminary findings of the North American Prodrome Longitudinal Study (NAPLS), a collaborative, multisite investigation into the earliest phase of psychotic illness. We describe how 8 independently conceived research projects were integrated methodologically, how diagnostic reliability was achieved across sites on the Structured Interview for Prodromal Syndromes, and how baseline and follow-up data were aggregated for 888 at risk and comparison subjects. Data are presented describing the demographic, academic/work, and diagnostic characteristics of 3 relevant subgroups: persons at heightened clinical risk for psychosis, help-seeking comparison subjects, and nonpsychiatric controls. The NAPLS data set will be used to explore a series of questions related to prodromal psychosis, including the descriptive phenomenology of currently accepted diagnostic criteria, conversion rates over a 30-month period, predictors of psychosis onset and functional disability, and the impact of early treatment on the course of prodromal symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17255119      PMCID: PMC2526151          DOI: 10.1093/schbul/sbl075

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.

Authors:  Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Don Linszen; Max Birchwood; Georg Juckel; Anthony Morrison; José Luis Vázquèz-Barquero; Martin Hambrecht; Heinrich VON Reventlow
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

2.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

3.  Overcoming barriers to research in early serious mental illness: issues for future collaboration.

Authors:  Robert K Heinssen; Bruce N Cuthbert; James Breiling; Lisa J Colpe; Regina Dolan-Sewell
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

4.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

5.  Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk.

Authors:  T H McGlashan; T J Miller; S W Woods
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

6.  Exemplification of a method for scaling life events: the Peri Life Events Scale.

Authors:  B S Dohrenwend; L Krasnoff; A R Askenasy; B P Dohrenwend
Journal:  J Health Soc Behav       Date:  1978-06

7.  Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior.

Authors:  D V Cicchetti; S A Sparrow
Journal:  Am J Ment Defic       Date:  1981-09

8.  Strauss (1969) revisited: a psychosis continuum in the general population?

Authors:  J van Os; M Hanssen; R V Bijl; A Ravelli
Journal:  Schizophr Res       Date:  2000-09-29       Impact factor: 4.939

Review 9.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

10.  The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.

Authors:  T J Miller; R B Zipursky; D Perkins; J Addington; S W Woods; K A Hawkins; R Hoffman; A Preda; I Epstein; D Addington; S Lindborg; E Marquez; M Tohen; A Breier; T H McGlashan
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

View more
  108 in total

1.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Risk factors for psychosis: impaired social and role functioning.

Authors:  Barbara A Cornblatt; Ricardo E Carrión; Jean Addington; Larry Seidman; Elaine F Walker; Tyronne D Cannon; Kristin S Cadenhead; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Robert Heinssen; Todd Lencz
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

3.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.

Authors:  Ian Kelleher; Aileen Murtagh; Charlene Molloy; Sarah Roddy; Mary C Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

4.  McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.

Authors:  Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
Journal:  J Clin Psychiatry       Date:  2010-07-13       Impact factor: 4.384

5.  Should "risk syndrome for psychosis" be included as a diagnosis in DSM-V?

Authors:  Amresh Shrivastava
Journal:  World Psychiatry       Date:  2010-06       Impact factor: 49.548

Review 6.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

7.  Progressive structural brain changes during development of psychosis.

Authors:  Tim B Ziermans; Patricia F Schothorst; Hugo G Schnack; P Cédric M P Koolschijn; René S Kahn; Herman van Engeland; Sarah Durston
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

Review 8.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

Review 9.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

10.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.